Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 2
Submit an article Journal homepage
194
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine

Makiko NakayamaDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanView further author information
, MD,
Annabelle A OkadaDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information
, MD,
Isami HayashiDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanView further author information
, MD,
Yoshimasa AndoDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanView further author information
, MD,
Takayo WatanabeDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanView further author information
, MD &
Hiroshi KeinoDepartment of Ophthalmology, Kyorin University School of Medicine, Tokyo, JapanView further author information
, MD
Pages 462-467 | Received 27 Sep 2021, Accepted 16 Nov 2021, Published online: 15 Feb 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shoichiro Niidome, Yoshihiko Usui, Kinya Tsubota, Risa Sugawara & Hiroshi Goto. (2023) COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report. Ocular Immunology and Inflammation 31:6, pages 1305-1309.
Read now

Articles from other publishers (1)

Parthopratim Dutta Majumder, Soumen Sadhu, Julio J González-López & Manabu Mochizuki. (2023) A COVID-19 perspective of Vogt–Koyanagi–Harada disease. Indian Journal of Ophthalmology 71:6, pages 2587-2591.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.